JPMorgan Chase & Co. Reiterates Overweight Rating for Shire (SHP)
Shire (LON:SHP)‘s stock had its “overweight” rating reaffirmed by research analysts at JPMorgan Chase & Co. in a report released on Tuesday, AnalystRatingsNetwork.com reports. They currently have a GBX 3,000 ($48.13) price target on the stock. JPMorgan Chase & Co.’s target price would suggest a potential upside of 25.68% from the company’s current price.
Shares of Shire (LON:SHP) traded down 1.28% during mid-day trading on Tuesday, hitting GBX 2387.00. 1,112,916 shares of the company’s stock traded hands. Shire has a 52-week low of GBX 1682.00 and a 52-week high of GBX 2602.00. The stock has a 50-day moving average of GBX 2432.08 and a 200-day moving average of GBX 2167.18. The company’s market cap is £13.119 billion.
Other equities research analysts have also recently issued reports about the stock. Analysts at Goldman Sachs Group Inc. reiterated a “conviction-buy” rating on shares of Shire in a research note to investors on Monday. Separately, analysts at BNP Paribas reiterated an “outperform” rating on shares of Shire in a research note to investors on Wednesday, October 2nd. They now have a GBX 2,700 ($43.32) price target on the stock. Finally, analysts at Citigroup Inc. reiterated a “buy” rating on shares of Shire in a research note to investors on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, five have given a hold rating, sixteen have issued a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of GBX 2,025.49 ($32.50).
Shire plc (LON:SHP) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.